UPCOMING EVENTS: MICROBIOTA INTERPRETATION IN A REAL CASE STUDY – 19 JUNE 2024

UPCOMING EVENTS: MICROBIOTA INTERPRETATION IN A REAL CASE – 19 JUNE

OPTIMISE AND PERSONALISE TREATMENTS THROUGH GENETICS

MyPharma personalised medicine test

In a broad sense, personalised medicine could be defined as medicine specifically adapted to each individual, not thinking of a group or set within the population, but of each person, so that treatments are adjusted as much as possible to the specific individual characteristics of each patient.

This concept is linked to knowledge of the patient’s genetics, since both the genome and the environment are responsible for the phenotype of the individual, which is the set of visible characteristics that an individual presents as a result of the interaction between his or her genotype and the environment.

Pharmacogenetics

Pharmacogenetics studies genetic variability in relation to the response to a drug in order to optimise its safety and efficacy.

Having this genetic information helps to determine the most appropriate drug for each patient and to adjust the dose to be administered more precisely. In other words, knowing this genetic variability makes it possible to optimise the pharmacological treatment for each patient in a personalised way. This increases the efficacy of the treatment and avoids possible adverse reactions.

This is particularly relevant on those occasions when, due to the severity of the disease, it is crucial to ensure the efficacy of the treatment and minimise the risk of toxicity.

Non-invasive

Once in a lifetime

Scientific evidence

Pharmacogenetics

What is MyPharma for?

MyPharma tests determine the presence/absence of problematic genetic variants associated with a wide range of medicines. This genetic information makes it possible to know:

  • Which drug and/or at what dose offers the greatest therapeutic benefits.
  • Which drug and/or at what dose adverse reactions are less likely to occur.

Introducing MyPharma, a test for personalised medicine

  • MyPharma is a genetic test that determines the presence/absence of problematic genetic variants associated with drugs.
  • MyPharma helps to establish a more effective and safer pharmacological treatment, as it allows to characterise the patient’s response to a wide range of drugs.
  • MyPharma is a non-invasive test. DNA is obtained from a saliva sample, is completely painless and is suitable for any person of any age.
  • MyPharma is performed once in a lifetime, your genetics do not change.
  • MyPharma analyses genetic markers with the highest level of scientific evidence.
  • Innovative technology that offers greater precision and depth in the results.
  • Once the sample has been received in the laboratory, you will receive your results within a maximum of 20 days.

Who is MyPharma aimed at?

To all professionals who wish to develop a pharmacological treatment with one or more drugs included in any of the MyPharma tests, and to those whose patients are already receiving treatment with any of the drugs analysed and who present adverse reactions and/or an inefficient response.

MINIMISE THE RISKS AND MAXIMISE THE BENEFITS OF THE MEDICATION

What do the MyPharma tests analyse?

These tests analyse genetic markers involved in the pharmacokinetics and pharmacodynamics of a wide range of drugs.  Overgenes has different MyPharma tests, each of which analyses different groups of drugs:

  • MyPharma Genetics: most common and widely used drugs.
  • MyPharma Pain: drugs for the treatment of pain.
  • MyPharma Neuro: drugs related to mental health.
  • MyPharma Onco: drugs for cancer treatment.

The following table shows the groups of drugs analysed by each test:

Drugs Genetics Pain Neuro Onco
Oncology treatment
Local anesthetics
Anxiolytics
Antidepressants
Antiepileptics
Antiinfectives
NSAIDs
Antipsychotics
Antipyretics
Cardiovascular
Corticosteroids
Opioids
Attention deficit treatment
Treatment of dementia
Smoking cessation treatment

CONTACT

Do you have any questions?
Get in touch with us.
NEW PRODUCT

MyMICROBIOME

GUT MICROBIOTA TEST